𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck

✍ Scribed by J. A. Werner; Anja-A. Dünne; B. J. Folz; R. Rochels; S. Bien; A. Ramaswamy; B. M. Lippert


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
372 KB
Volume
258
Category
Article
ISSN
0302-9530

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Treatment guideline for hemangiomas and
✍ Jia Wei Zheng; Qin Zhou; Xiu Juan Yang; Yan An Wang; Xin Dong Fan; Guo Yu Zhou; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

## Abstract Vascular anomalies are among the most common congenital and neonatal dysmorphogenesis, which are separated into hemangiomas and vascular malformations. They can occur in various areas throughout the body, with 60% being located in the head and neck. The true mechanism of pathogenesis of

Treatment of a large hemangioma in the h
✍ Smith, Arlan R. ;Van Urk, H. ;Vaandrager, M. ;Van Der Meulen, J. C. 📂 Article 📅 1983 🏛 Wiley (John Wiley & Sons) ⚖ 526 KB

A 15-year-old girl with a large hemangioma in the head and neck region was treated with selective ernbolization and microvascular reconstructive surgery (using a free latissimus dorsi flap) to cover the defect after total ablative surgery.

Embolization with “Ethibloc” of vascular
✍ D. Kühne; K. Helmke 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 555 KB

"Ethibloc" has been used almost exclusively until now for embolization of tumors and bleeding vessels in the liver and kidney. Unlike with Gelfoam-particles, there is no recanalization. The resorption occurs so slowly that there is no interference with the necrosis of the embolized tumor. Due to its

Interstitial photodynamic therapy for a
✍ Christian S. Betz; H. Rolf Jäger; Jocelyn A.S. Brookes; Robin Richards; Andreas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB

## Abstract ## Background and Objectives Photodynamic therapy is based on an interaction of a drug and light in oxygenated tissue. The photosensitizing drug Foscan® is licensed in the EU for the treatment of advanced head and neck cancer. The light can be applied by surface illumination or directl